Nico Aelmans (Group CEO) is pleased to announce that in order to cater for growth Research and Medical Chemicals Group (RMC) of which Buchem BV is an integral part has reinforced the management structure by following nominations as per 1st February 2022.

Johan Leugs will assume the responsibility of Chief Operating Officer

Luc Amkreutz has been appointed Chief Financial Officer

Casper (John) Frijns will support the group as Chief Marketing and Sales Officer

With these appointments RMC will be able to further drive the integration of Buchem’s sister companies ReseaChem GmbH and Swant AG as well as preparing the ground for further acquisitions.

It is our pleasure to introduce Mr. Nico Aelmans as our new managing director since the beginning of 2021.

ReseaChem has now been integrated into Research and Medical Chemicals Group (RMC); a team of international companies. Among them is Buchem BV from the Netherlands, which are specialized in developing, manufacturing and worldwide selling of chemicals for the laboratory, hospital and chemical market.

In the near future, we will be able to build a strong center of excellence for MedChem and   R&D-services thanks to the combination of our synergetic energies and thereby expand our abilities, know-how and customer care.

We are looking forward to work together with you!